These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1303261)

  • 1. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome.
    Smith SA; Easton DF; Evans DG; Ponder BA
    Nat Genet; 1992 Oct; 2(2):128-31. PubMed ID: 1303261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of allelic losses on 17q12-q21 chromosomal region in benign lesions and malignant tumors occurring in a familial context.
    Lalle P; De Latour M; Rio P; Bignon YJ
    Oncogene; 1994 Feb; 9(2):437-42. PubMed ID: 8290255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
    Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
    Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for BRCA1.
    Friedman LS; Ostermeyer EA; Lynch ED; Szabo CI; Anderson LA; Dowd P; Lee MK; Rowell SE; Boyd J; King MC
    Cancer Res; 1994 Dec; 54(24):6374-82. PubMed ID: 7987831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
    Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
    Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysis.
    Sobol H; Mazoyer S; Smith SA; Lyonnet D; Bignon YJ; Narod SA; Ardoin A; Biron P; Bobin JY; Bremond A
    Bull Cancer; 1993 Feb; 80(2):121-34. PubMed ID: 8173163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
    Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
    Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
    Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
    Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The search for the familial breast/ovarian cancer gene.
    Black DM; Solomon E
    Trends Genet; 1993 Jan; 9(1):22-6. PubMed ID: 8434413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
    Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
    J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer.
    Cooke IE; Shelling AN; Le Meuth VG; Charnock ML; Ganesan TS
    Genes Chromosomes Cancer; 1996 Apr; 15(4):223-33. PubMed ID: 8703848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of genetic factors for development of breast cancer].
    Chang-Claude J; Eby N; Becher H
    Zentralbl Gynakol; 1994; 116(12):660-9. PubMed ID: 7846977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary predisposition for cancer of the breast and the ovary].
    Lalle P; Stoppa-Lyonnet D; Mazoyer S; Rio P; Girodet C; Hardouin A; Narod SA; Sobol H; Bignon YJ
    Bull Cancer; 1993 Oct; 80(10):857-65. PubMed ID: 8204923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of breast cancer pedigrees using affected sibship methods.
    Barrett JH; Rigby AS
    Genet Epidemiol; 1995; 12(6):847-51. PubMed ID: 8788020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.
    Collins N; McManus R; Wooster R; Mangion J; Seal S; Lakhani SR; Ormiston W; Daly PA; Ford D; Easton DF
    Oncogene; 1995 Apr; 10(8):1673-5. PubMed ID: 7731724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele loss from chromosome 17 in ovarian cancer.
    Russell SE; Hickey GI; Lowry WS; White P; Atkinson RJ
    Oncogene; 1990 Oct; 5(10):1581-3. PubMed ID: 2250914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors.
    Kalikin LM; Frank TS; Svoboda-Newman SM; Wetzel JC; Cooney KA; Petty EM
    Oncogene; 1997 Apr; 14(16):1991-4. PubMed ID: 9150366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.
    Eccles DM; Russell SE; Haites NE; Atkinson R; Bell DW; Gruber L; Hickey I; Kelly K; Kitchener H; Leonard R
    Oncogene; 1992 Oct; 7(10):2069-72. PubMed ID: 1408149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.